Skip to main content
. Author manuscript; available in PMC: 2022 Dec 12.
Published in final edited form as: Ann Oncol. 2019 Dec 9;31(3):412–421. doi: 10.1016/j.annonc.2019.11.018

Figure 2. Progression-free survival and (B) overall survival in patients with HER2 amplification and/or overexpression (n = 15).

Figure 2.

(A) HER2, human epidermal growth factor receptor 2.